
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Desheng Yang, Shuang Chang, Fuchun Li, et al.
IUBMB Life (2021) Vol. 73, Iss. 11, pp. 1325-1333
Open Access | Times Cited: 46
Showing 1-25 of 46 citing articles:
The role of m6A RNA methylation in cancer metabolism
Yuanyuan An, Hua Duan
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 483
Yuanyuan An, Hua Duan
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 483
m6A-regulated tumor glycolysis: new advances in epigenetics and metabolism
Shiwei Yue, Hailing Liu, Hong-Fei Su, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 47
Shiwei Yue, Hailing Liu, Hong-Fei Su, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 47
RNA modifications in cellular metabolism: implications for metabolism-targeted therapy and immunotherapy
Weiwei Liu, Si-Qing Zheng, Li Tian, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 34
Weiwei Liu, Si-Qing Zheng, Li Tian, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 34
Critical roles and clinical perspectives of RNA methylation in cancer
Ganglei Li, Qinfan Yao, Peixi Liu, et al.
MedComm (2024) Vol. 5, Iss. 5
Open Access | Times Cited: 17
Ganglei Li, Qinfan Yao, Peixi Liu, et al.
MedComm (2024) Vol. 5, Iss. 5
Open Access | Times Cited: 17
Crosstalk among m6A RNA methylation, hypoxia and metabolic reprogramming in TME: from immunosuppressive microenvironment to clinical application
Fusheng Zhang, Haiyang Liu, Meiqi Duan, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 60
Fusheng Zhang, Haiyang Liu, Meiqi Duan, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 60
KIAA1429 promotes tumorigenesis and gefitinib resistance in lung adenocarcinoma by activating the JNK/ MAPK pathway in an m6A-dependent manner
Xi Lin, Rongyi Ye, Zhiming Li, et al.
Drug Resistance Updates (2022) Vol. 66, pp. 100908-100908
Open Access | Times Cited: 56
Xi Lin, Rongyi Ye, Zhiming Li, et al.
Drug Resistance Updates (2022) Vol. 66, pp. 100908-100908
Open Access | Times Cited: 56
m6A writer WTAP targets NRF2 to accelerate bladder cancer malignancy via m6A-dependent ferroptosis regulation
Ke Wang, Gang Wang, Gang Li, et al.
APOPTOSIS (2023) Vol. 28, Iss. 3-4, pp. 627-638
Closed Access | Times Cited: 39
Ke Wang, Gang Wang, Gang Li, et al.
APOPTOSIS (2023) Vol. 28, Iss. 3-4, pp. 627-638
Closed Access | Times Cited: 39
The roles of N6-methyladenosine and its target regulatory noncoding RNAs in tumors: classification, mechanisms, and potential therapeutic implications
Ziying Liu, Lei Gao, Long Cheng, et al.
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 3, pp. 487-501
Open Access | Times Cited: 39
Ziying Liu, Lei Gao, Long Cheng, et al.
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 3, pp. 487-501
Open Access | Times Cited: 39
N6-methyladenosine RNA methylation in diabetic kidney disease
Jiaan Huang, Fan Yang, Yan Liu, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 171, pp. 116185-116185
Open Access | Times Cited: 11
Jiaan Huang, Fan Yang, Yan Liu, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 171, pp. 116185-116185
Open Access | Times Cited: 11
Emerging role of RNA modification and long noncoding RNA interaction in cancer
Liqiong Yang, Lu Tang, Qi Min, et al.
Cancer Gene Therapy (2024) Vol. 31, Iss. 6, pp. 816-830
Open Access | Times Cited: 11
Liqiong Yang, Lu Tang, Qi Min, et al.
Cancer Gene Therapy (2024) Vol. 31, Iss. 6, pp. 816-830
Open Access | Times Cited: 11
N6-methyladenosine modification and metabolic reprogramming of digestive system malignancies
Xianlei Cai, Chao Liang, Miaozun Zhang, et al.
Cancer Letters (2022) Vol. 544, pp. 215815-215815
Closed Access | Times Cited: 31
Xianlei Cai, Chao Liang, Miaozun Zhang, et al.
Cancer Letters (2022) Vol. 544, pp. 215815-215815
Closed Access | Times Cited: 31
The biological function of m6A methyltransferase KIAA1429 and its role in human disease
Xiaoyu Zhang, Meng jiao Li, Lei Xia, et al.
PeerJ (2022) Vol. 10, pp. e14334-e14334
Open Access | Times Cited: 26
Xiaoyu Zhang, Meng jiao Li, Lei Xia, et al.
PeerJ (2022) Vol. 10, pp. e14334-e14334
Open Access | Times Cited: 26
N6-methyladenosine (m6A) reader IGF2BP1 accelerates gastric cancer aerobic glycolysis in c-Myc-dependent manner
Fan Luo, Kai Lin
Experimental Cell Research (2022) Vol. 417, Iss. 1, pp. 113176-113176
Closed Access | Times Cited: 24
Fan Luo, Kai Lin
Experimental Cell Research (2022) Vol. 417, Iss. 1, pp. 113176-113176
Closed Access | Times Cited: 24
Novel insights into mutual regulation between N6-methyladenosine modification and LncRNAs in tumors
Nan Zhang, Yifei Sun, Zongqin Mei, et al.
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 14
Nan Zhang, Yifei Sun, Zongqin Mei, et al.
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 14
Glycolysis and tumor progression promoted by the m6A writer VIRMA via m6A-dependent upregulation of STRA6 in pancreatic ductal adenocarcinoma
Kege Yang, Ziyi Zhong, Jinmao Zou, et al.
Cancer Letters (2024) Vol. 590, pp. 216840-216840
Closed Access | Times Cited: 6
Kege Yang, Ziyi Zhong, Jinmao Zou, et al.
Cancer Letters (2024) Vol. 590, pp. 216840-216840
Closed Access | Times Cited: 6
N6-methylation in the development, diagnosis, and treatment of gastric cancer
Jiaxin Wang, Guiping Zhao, Yan Zhao, et al.
Journal of Translational Internal Medicine (2024) Vol. 12, Iss. 1, pp. 5-21
Open Access | Times Cited: 5
Jiaxin Wang, Guiping Zhao, Yan Zhao, et al.
Journal of Translational Internal Medicine (2024) Vol. 12, Iss. 1, pp. 5-21
Open Access | Times Cited: 5
KIAA1429 increases FOXM1 expression through YTHDF1–mediated m6A modification to promote aerobic glycolysis and tumorigenesis in multiple myeloma
Yue Wu, Y. Luo, Xingchen Yao, et al.
Cell Biology and Toxicology (2024) Vol. 40, Iss. 1
Open Access | Times Cited: 5
Yue Wu, Y. Luo, Xingchen Yao, et al.
Cell Biology and Toxicology (2024) Vol. 40, Iss. 1
Open Access | Times Cited: 5
N6-methyladenosine (m6A) reader IGF2BP2 promotes gastric cancer progression via targeting SIRT1
Zili Zhang, Yu Xing, Wenqing Gao, et al.
Bioengineered (2022) Vol. 13, Iss. 5, pp. 11541-11550
Open Access | Times Cited: 20
Zili Zhang, Yu Xing, Wenqing Gao, et al.
Bioengineered (2022) Vol. 13, Iss. 5, pp. 11541-11550
Open Access | Times Cited: 20
Reprogramming of central carbon metabolism in hepatocellular carcinoma
Haoming Xia, Ziyue Huang, Yi Xu, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 153, pp. 113485-113485
Open Access | Times Cited: 19
Haoming Xia, Ziyue Huang, Yi Xu, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 153, pp. 113485-113485
Open Access | Times Cited: 19
m6A Methyltransferase KIAA1429 Regulates the Cisplatin Sensitivity of Gastric Cancer Cells via Stabilizing FOXM1 mRNA
Zhongcheng Zhu, Yuan Zhou, Yongheng Chen, et al.
Cancers (2022) Vol. 14, Iss. 20, pp. 5025-5025
Open Access | Times Cited: 19
Zhongcheng Zhu, Yuan Zhou, Yongheng Chen, et al.
Cancers (2022) Vol. 14, Iss. 20, pp. 5025-5025
Open Access | Times Cited: 19
m6A transferase KIAA1429 mediates the upregulation of LncRNA LINC00968 promoting the progression of gastric cancer cells
Huijun Liu, Menghan Yang, Chunyue Zhang, et al.
Hereditas (2025) Vol. 162, Iss. 1
Open Access
Huijun Liu, Menghan Yang, Chunyue Zhang, et al.
Hereditas (2025) Vol. 162, Iss. 1
Open Access
N6-methyladenosine RNA modification in stomach carcinoma: Novel insights into mechanisms and implications for diagnosis and treatment
Zhengmao Lu, Zhaojie Lyu, Peixin Dong, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2025) Vol. 1871, Iss. 5, pp. 167793-167793
Closed Access
Zhengmao Lu, Zhaojie Lyu, Peixin Dong, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2025) Vol. 1871, Iss. 5, pp. 167793-167793
Closed Access
A therapeutic role for a regulatory glucose transporter1 (Glut1)-associated natural antisense transcript
Maoxue Tang, Shu‐Chun Teng, Yueqing Peng, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
Maoxue Tang, Shu‐Chun Teng, Yueqing Peng, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
LINC00958: A promising long non-coding RNA related to cancer
Hongxu Li, Jie Gao, Long Liu, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 151, pp. 113087-113087
Open Access | Times Cited: 16
Hongxu Li, Jie Gao, Long Liu, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 151, pp. 113087-113087
Open Access | Times Cited: 16
The regulatory role of N6-methyladenosine RNA modification in gastric cancer: Molecular mechanisms and potential therapeutic targets
Gaofeng Li, Qiru Fu, Cong Liu, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 16
Gaofeng Li, Qiru Fu, Cong Liu, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 16